Stocks and Investing Stocks and Investing
Wed, August 17, 2022
Tue, August 16, 2022
Mon, August 15, 2022
Fri, August 12, 2022

Jonathan Chang Maintained (VINC) at Buy with Decreased Target to $5 on, Aug 12th, 2022


Published on 2024-10-27 22:38:33 - WOPRAI, Jonathan Chang
  Print publication without navigation


Jonathan Chang of SVB Leerink, Maintained "Vincerx Pharma, Inc." (VINC) at Buy with Decreased Target from $6 to $5 on, Aug 12th, 2022.

Jonathan has made no other calls on VINC in the last 4 months.



There are 3 other peers that have a rating on VINC. Out of the 3 peers that are also analyzing VINC, 0 agree with Jonathan's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Jonathan


  • Li Watsek of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $8 on, Wednesday, June 8th, 2022
  • Matthew Barcus of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $4 on, Tuesday, June 7th, 2022
  • Kalpit Patel of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $6 on, Tuesday, June 7th, 2022